Researchers report case of bone marrow transplant patient off ART for 288 days without HIV rebound
New HIV capsid inhibitors show high potency and prolonged activity in early studies
Integrase inhibitors may increase risk of IRIS in late presenters for HIV treatment
Monoclonal antibodies show promise for HIV-positive people with limited treatment options
New NNRTI doravirine shows good efficacy in phase 3 study
Time spent by people in HIV care in US with a transmissible viral load has fallen by three-quarters since 2000
Tenofovir/emtricitabine/efavirenz less likely to cause adverse birth outcomes than other regimens, Botswana study finds
Experimental STI prophylaxis in PrEP users produces big drops in syphilis and chlamydia infections but not in gonorrhoea
Changes in viral suppression over time reveal disparities in HIV care in the United States
